Australia

Our Promise: Pharma-quality
Cannabis Products

MediPharm Labs brings a pharmaceutical perspective to the cannabis industry, working to internationally recognised medicines standards which result in products that are PURE and TRUSTED for patients.

Pharmaceutical Standards & Quality

MediPharm Labs Australia's state-of-the-art cannabis extraction facility is Good Manufacturing Practices (GMP) certified and is designed with ISO standard cleanrooms and critical environments

Our strict manufacturing processes result in pharmaceutical-quality products for patients.

Email Alerts

Stay informed and receive company updates straight to your inbox

Sign up today

Global Leader in Extraction

Expansion Map

MediPharm Labs Australia is located in Wonthaggi, Victoria 130km southeast of Melbourne. We have developed our operations there to the same high standards to mirror our Canadian facility. This trusted cannabis extraction operation will service Australia’s growing medical cannabis industry while also being an import-export hub for the Asia-Pacific region.

Our Expert Management Team

Warren Everitt

Chief Executive Officer, Asia Pacific

Warren Everitt

Warren Everitt

Chief Executive Officer, Asia Pacific

Warren brings a wealth of senior leadership to MediPharm Labs Australia, having run both his own small businesses as well as achieved success in the Asia Pacific for a leading international digital marketing agency. Warren completed an Honours Bachelor Computer Science (programming) and was on the leading edge of web development and digital marketing, working first in Canada and the UK before building the Asia Pacific division of a large enterprise marketing agency, MarketOne. Over 8 years, Warren opened four offices, adding 200+ staff in Melbourne, Singapore, Bangalore and Tokyo. He boasts a 15-year history in sales and marketing, consulting to some of the biggest companies in the world.

Dr. Jake Golding

Director of Operations, Asia Pacific

Dr. Jake Golding

Dr. Jake Golding

Director of Operations, Asia Pacific

Jake has nearly 20 years of experience in the bio-tech, medical device and pharmaceutical fields, in the development and commercialisation of a variety of products. After completing his BSc. and Doctorate degrees in Chemistry, he joined the Commonwealth Scientific and Industrial Research Organisation as a post-doctoral fellow. He then transitioned into private industry joining Southern Dental International in product development before moving to Boron Molecular taking up Operational and Quality Manager positions. With a wide range of experience in process and production chemistry, Dr. Golding comes to MediPharm Labs with a wealth of expertise in the registration, qualification and validation of processes, facilities and equipment, as well as the development and maintenance of quality systems. Jake most recently served as the Head of Quality at Medical Developments Australia. 

Kate Larsen

Head of Regulatory Affairs, Asia Pacific

Kate Larsen

Kate Larsen

Head of Regulatory Affairs, Asia Pacific

Kate is a regulatory affairs specialist with expertise in innovator product development. Kate has successfully registered speciality prescription drugs in Australia and New Zealand and was the regulatory manufacturing lead for US IND and European registration applications. She is experienced in the many facets of product development and compliance including: manufacturing and quality; clinical trials; safety and toxicity; named patient access (i.e. SAS in AU, S29 in NZ); packaging and labelling; product testing; and, import and export processes. Kate has over 10 years’ experience in Regulatory Affairs in the pharmaceutical and nutrition industries, working across biological products, medical devices, sports nutrition and supplements and, most recently, inhaled chemical/device analgesic at Medical Developments International.

James Lee

Head of Project Management & Engineering, Asia Pacific

James Lee

James Lee

Head of Project Management & Engineering, Asia Pacific

James joined the MediPharm Labs team with over 15 years of professional experience spanning multiple GMP manufacturing and commercial industries. Initially beginning his career as an extensively qualified Maintenance Electrician, he has gone on to successfully manage, lead and mentor specialist engineering project and maintenance teams within highly regulated pharmaceutical manufacturing environments. Having been recognised for his achievements within industry, James was granted a partial scholarship to complete a Master’s Degree in Project Management at the School of Property, Construction and Project Management, RMIT University, and has since gained professional accreditation from both the Project Management Institute (PMP®) and Australian Institute of Project Management (CPPP®).

Rebecca Bond

Director of Finance, Asia Pacific

Rebecca Bond

Rebecca Bond

Director of Finance, Asia Pacific

As a Chartered Accountant since 1999, Rebecca has worked with many organizations in both private practice and industry. Rebecca has acted as a Financial Controller for both national and global organisations. Rebecca has previous experience in the pharmaceutical industry working as a financial analyst for GlaxoSmithKline. Rebecca lectures in Taxation Law, Management Accounting and Applied Finance for Chartered Accountants Australia and New Zealand. Rebecca holds a Bachelor of Business Major in Accounting, is a member of Chartered Accountants Australia and New Zealand, and holds a Graduate Certificate in Financial Planning.

Andrew Collett

General Counsel, Asia Pacific

Andrew Collett

Andrew Collett

General Counsel, Asia Pacific

Andrew joins MediPharm with a wealth of experience gained from both private legal practice and as in-house counsel for several large corporations. His extensive experience includes almost 7 years with a large multinational logistics company, where he was involved in the full spectrum of supply chain matters. This encompassed mergers & acquisition, joint ventures, regulatory compliance and corporate governance issues. Additionally, Andrew has also worked as in-house counsel for a petroleum company and a waste & environmental services company. During his career both in private practice and as in-house counsel, Andrew has successfully managed a number of complex and high-profile litigation matters in a variety of State and Federal Courts. Andrew has also held directorships on several boards. He holds a Bachelor of Laws, Bachelor of Business (Banking & Finance) and Master of Laws from Monash University.

Andrew Cormack

Head of Production, Asia Pacific

Andrew Cormack

Andrew Cormack

Head of Production, Asia Pacific

A senior production manager in the pharmaceutical, nutraceutical and food industries, Andrew brings more than a dozen years’ experience establishing, operating and certifying GMP manufacturing facilities. Goal-oriented, safety-minded, and a specialist in project management and planning with Six Sigma training, Andrew has managed product launches, facility buildouts and hundreds of employees over his career. At COSMAX NBT, Andrew’s teams produced more than 250 million doses of softgels, solid dose tablets, powdered sachets and/or supplements per month. At global pharmaceutical contract manufacturer, Catalent, Inc. Andrew created a workplace culture steeped in safe practices and oriented to achieving quality and cost performance objectives. Through improved resource planning and staff training at Mondelēz Australia Pty Ltd., Andrew achieved efficiencies in chocolate moulding/finishing.

Adam Isaac Miller

Head of Strategic Accounts, Asia Pacific

Adam Isaac Miller

Adam Isaac Miller

Head of Strategic Accounts, Asia Pacific

Prior to joining MediPharm Labs, Adam spent over 8 years building various B2B businesses within education, investment, and medicinal cannabis, with progressive roles including business development, strategy, product development and project management. He has consulted private and listed cannabis producers and ancillary businesses since 2015, as one of the early entrants and experts in the burgeoning Australian cannabis industry. Adam founded and currently sits on the board of The Medical Cannabis Council, Australia’s largest not-for-profit industry body. He is a frequent public speaker and publishes a widely read industry newsletter. Adam earned a Bachelor of Entrepreneurship from the Royal Melbourne Institute of Technology.

Career Opportunities

Join one of the most innovative companies in this exciting new industry.

Email your application to:
[email protected]

Awards

Awards

On August 1st, MediPharm Labs Australia received the 2019 INNOVATION AWARD from the Australian Cannabis Industry Awards. The awards are designed to honour Australian cannabis community pioneers and business professionals for industry innovation and social progression. MediPharm Labs Australia was recognized for bringing new and exciting innovation to cannabis.

MediPharm Labs Australia has played an important role in advancing the cannabis industry. In Australia, cultivators can only apply for their licence if paired with a processor, because this medicinal cannabis market only allows concentrate-based products (no smoking of flower)). In its capacity as a processor, MediPharm Labs Australia has been a named partner on dozens of domestic Australian cultivator licence applications.

Events